Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in STEMI Patients Undergoing PCI
2006-003819-45Phase 3Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Oct 2006
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Epoetin beta arm with Placebo arm (2 arms). Primary endpoint: Left ventricular ejection fraction at 4–6 months. Started Oct 2006; status: completed.
02
Drugs
epoetin beta
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2006-003819-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003819-45.